Douglas Kyle Hogarth to Esophageal Neoplasms
This is a "connection" page, showing publications Douglas Kyle Hogarth has written about Esophageal Neoplasms.
Connection Strength
0.158
-
Personalized Antibodies for Gastroesophageal Adenocarcinoma (PANGEA): A Phase II Study Evaluating an Individualized Treatment Strategy for Metastatic Disease. Cancer Discov. 2021 02; 11(2):308-325.
Score: 0.158